Aliases & Classifications for Trichomoniasis

MalaCards integrated aliases for Trichomoniasis:

Name: Trichomoniasis 12 72 51 40 3 14
Trichomonas Infections 41 69
Trichomonas Infection 12

Classifications:



External Ids:

Disease Ontology 12 DOID:1947
ICD10 32 A59 A59.9
ICD9CM 34 131 131.9
MeSH 41 D014245
NCIt 46 C35720
UMLS 69 C0040921

Summaries for Trichomoniasis

MedlinePlus : 40 Trichomoniasis is a sexually transmitted disease caused by a parasite. It spreads from person to person during sex. Many people do not have any symptoms. If you do get symptoms, they usually happen within 5 to 28 days after being infected. It can cause vaginitis in women. Symptoms include Yellow-green or gray discharge from the vagina Discomfort during sex Vaginal odor Painful urination Itching burning, and soreness of the vagina and vulva Most men do not have symptoms. If they do, they may have Itching or irritation inside the penis Burning after urination or ejaculation Discharge from the penis Trichomoniasis can increase the risk of getting or spreading other sexually transmitted diseases. Pregnant women with trichomoniasis are more likely to give birth too early, and their babies are more likely have a low birth weight. Lab tests can tell if you have the infection. Treatment is with antibiotics. If you are infected, you and your partner must be treated. Correct usage of latex condoms greatly reduces, but does not eliminate, the risk of catching or spreading trichomoniasis. The most reliable way to avoid infection is to not have anal, vaginal, or oral sex. Centers for Disease Control and Prevention

MalaCards based summary : Trichomoniasis, also known as trichomonas infections, is related to cervicitis and vulvovaginal candidiasis, and has symptoms including pruritus, pelvic pain and fever. An important gene associated with Trichomoniasis is IL2 (Interleukin 2), and among its related pathways/superpathways are NF-kappaB Signaling and Immune response IFN alpha/beta signaling pathway. The drugs Acetylcysteine and Metronidazole have been mentioned in the context of this disorder. Affiliated tissues include testes, t cells and cervix.

CDC : 3 Women: trichomoniasis can cause problems with your pregnancy. Talk with your doctor about it.

Disease Ontology : 12 A parasitic protozoa infectious disease that is caused by singled-celled protozoan parasites Trichomonas vaginalis or Trichomonas tenax, which infect the urogenital tract and mouth respectively.

Wikipedia : 72 Trichomoniasis (trich) is an infectious disease caused by the parasite Trichomonas vaginalis. About 70%... more...

Related Diseases for Trichomoniasis

Diseases related to Trichomoniasis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 93)
# Related Disease Score Top Affiliating Genes
1 cervicitis 30.7 CD79A IL2
2 vulvovaginal candidiasis 30.4 CD79A IL2
3 urethritis 30.3 CD79A EXTL3
4 syphilis 30.2 CD79A EXTL3
5 chlamydia 29.9 CD79A CXCL8
6 vaginitis 11.7
7 dientamoebiasis 11.1
8 farmer's lung 10.4 CD79A IL2
9 early yaws 10.4 CD79A EXTL3
10 congenital syphilis 10.4 CD79A EXTL3
11 secondary syphilis 10.4 CD79A EXTL3
12 microscopic colitis 10.4 CD79A IL2
13 chorioretinitis 10.4 CD79A EXTL3
14 asymptomatic neurosyphilis 10.3 CD79A EXTL3
15 candidiasis 10.3
16 tabes dorsalis 10.3 CD79A EXTL3
17 coccidiosis 10.3 CD79A IL2
18 erythema multiforme 10.3 CD79A IL2
19 bacterial vaginosis 10.3
20 commensal bacterial infectious disease 10.3 CD79A IL2
21 hypersensitivity reaction type iv disease 10.3 CD79A IL2
22 exanthem 10.3 CD79A IL2
23 tertiary neurosyphilis 10.3 CD79A EXTL3
24 vernal conjunctivitis 10.3 CD79A IL2
25 leprosy 3 10.2 CD79A IL2
26 toxicodendron dermatitis 10.2 CXCL8 IL2
27 streptococcal toxic-shock syndrome 10.2 CXCL8 IL2
28 human immunodeficiency virus infectious disease 10.2 CD79A IL2
29 retinitis pigmentosa 44 10.2 CXCL8 IL2
30 crohn's colitis 10.2 CXCL8 IL2
31 capillary leak syndrome 10.2 CXCL8 IL2
32 parasitic protozoa infectious disease 10.2 CD79A IL2
33 necrotizing fasciitis 10.2 CXCL8 IL2
34 wells syndrome 10.2 CXCL8 IL2
35 exudative glomerulonephritis 10.2 CD79A CXCL8
36 erythema elevatum diutinum 10.2 CD79A CXCL8
37 pleurisy 10.1 CXCL8 IL2
38 primary bacterial infectious disease 10.1 CD79A EXTL3 IL2
39 plasmacytoma 10.1 CD79A IL2
40 periodontosis 10.1 CD79A CXCL8
41 vaginal discharge 10.1
42 bacteriuria 10.1 CD79A CXCL8
43 brucellosis 10.1 CXCL8 IL2
44 middle ear disease 10.1 CD79A CXCL8
45 invasive aspergillosis 10.1 CD79A CXCL8
46 nasal cavity disease 10.1 CD79A CXCL8
47 nose disease 10.1 CD79A CXCL8
48 stomach disease 10.0 CD79A CXCL8
49 upper respiratory tract disease 10.0 CD79A CXCL8
50 conjunctivitis 10.0 CXCL8 IL2

Comorbidity relations with Trichomoniasis via Phenotypic Disease Network (PDN):


Acute Cystitis Hypertension, Essential

Graphical network of the top 20 diseases related to Trichomoniasis:



Diseases related to Trichomoniasis

Symptoms & Phenotypes for Trichomoniasis

UMLS symptoms related to Trichomoniasis:


pruritus, pelvic pain, fever

Drugs & Therapeutics for Trichomoniasis

Drugs for Trichomoniasis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 83)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Acetylcysteine Approved, Investigational Phase 4 616-91-1 12035
2
Metronidazole Approved Phase 4,Phase 3,Phase 2,Early Phase 1 443-48-1 4173
3
Clindamycin Approved, Vet_approved Phase 4,Early Phase 1 18323-44-9 29029
4
Clotrimazole Approved, Vet_approved Phase 4,Phase 3 23593-75-1 2812
5 Anti-Bacterial Agents Phase 4,Phase 2,Early Phase 1
6 Antibiotics, Antitubercular Phase 4
7 Antidotes Phase 4
8 Anti-Infective Agents Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
9 Antioxidants Phase 4
10 Antiparasitic Agents Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
11 Antiprotozoal Agents Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
12 Antiviral Agents Phase 4
13 Expectorants Phase 4
14 N-monoacetylcystine Phase 4
15 Protective Agents Phase 4
16 Respiratory System Agents Phase 4
17 Clindamycin palmitate Phase 4,Early Phase 1
18 Clindamycin phosphate Phase 4,Early Phase 1
19 cysteine Nutraceutical Phase 4
20
Fluconazole Approved, Investigational Phase 3,Early Phase 1 86386-73-4 3365
21
Miconazole Approved, Investigational, Vet_approved Phase 3,Phase 2,Early Phase 1 22916-47-8 4189
22
Secnidazole Approved Phase 3 3366-95-8
23
Ethanol Approved Phase 3 64-17-5 702
24
Tinidazole Approved, Investigational Phase 3,Phase 2,Phase 1 19387-91-8 5479
25
Azithromycin Approved Phase 3,Phase 2 83905-01-5 53477736 447043 55185
26
Pyrimethamine Approved, Investigational, Vet_approved Phase 3 58-14-0 4993
27
Sulfadoxine Approved, Investigational Phase 3 2447-57-6 17134
28
Iron Approved Phase 3 7439-89-6 23925
29
chloroquine Approved, Investigational, Vet_approved Phase 3 54-05-7 2719
30
Folic Acid Approved, Nutraceutical, Vet_approved Phase 3 59-30-3 6037
31
leucovorin Approved, Nutraceutical Phase 3 58-05-9 143 6006
32 Contraceptive Agents Phase 3
33 Antifungal Agents Phase 3,Phase 2,Early Phase 1
34 Cytochrome P-450 CYP2C9 Inhibitors Phase 3,Phase 2,Early Phase 1
35 Cytochrome P-450 Enzyme Inhibitors Phase 3,Phase 2,Early Phase 1
36 Hormone Antagonists Phase 3,Phase 2,Early Phase 1
37 Hormones Phase 3,Phase 2,Early Phase 1
38 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 3,Phase 2,Early Phase 1
39 Steroid Synthesis Inhibitors Phase 3,Phase 2,Early Phase 1
40 Alkylating Agents Phase 3,Phase 2,Phase 1
41 Antimalarials Phase 3,Phase 2
42 Fanasil, pyrimethamine drug combination Phase 3
43 Folic Acid Antagonists Phase 3
44 Renal Agents Phase 3
45 Vitamin B Complex Phase 3
46 Calcium, Dietary Phase 3
47 Micronutrients Phase 3
48 Trace Elements Phase 3
49 Artemisinine Phase 3
50 Artemisinins Phase 3

Interventional clinical trials:

(show top 50) (show all 69)

# Name Status NCT ID Phase Drugs
1 Role of N-Acetylcysteine in Treatment of Bacterial Vaginosis Unknown status NCT01841411 Phase 4 N-Acetyl cysteine;Metronidazole + N-Acetyl cysteine;metronidazole
2 DNA Clearance of Uncomplicated Trichomonas Vaginalis Infections in HIV Negative Women Completed NCT01874158 Phase 4
3 Trichomonas Vaginalis Recurrence Among HIV+ Women Completed NCT01018095 Phase 4 Metronidazole
4 Comparison of Two Topical Formulations Containing Clindamycin and Clotrimazole in Patients With Vaginal Infections Completed NCT01697826 Phase 4 ClinSupV3 -soft gelatin capsule;ClinSupV3ER- Extended release tablet
5 Trichomonas Vaginalis Repeat Infections Among HIV Negative Women Completed NCT01832480 Phase 3 MTZ 500 mg BID x 7 days;MTZ 2 g
6 Intravaginal Treatment of Disturbances of Vaginal Flora Among HIV Infected and Uninfected Women in Malawi Completed NCT00140764 Phase 3 Metronidazole gel versus placebo gel
7 Efficacy Study of the Vaginal Gel Carraguard to Prevent HIV Transmission Completed NCT00213083 Phase 3 Carraguard (PC-515)
8 Safety and Clinical and Microbiological Efficacy of the Combination of Fluconazole and Secnidazole for the Treatment of Symptomatic Vaginal Discharge Completed NCT02111629 Phase 3 Fluconazole and Secnidazole
9 Effectiveness of a Community-level HIV/STD Prevention Intervention in Promoting Safer Sexual Behaviors in High-risk Populations Completed NCT00710060 Phase 3
10 A Multicenter, Open-Label, Non-Comparative Study of the Safety and Contraceptive Efficacy of the Woman's Condom Completed NCT01223313 Phase 3
11 Study of the Management of Vaginal Discharge in West African Using Single Dose Treatments Completed NCT00313131 Phase 3 tinidazole+fluconazole vs metronidazole+clotrimazole
12 MEMA Kwa Vijana Trial: Impact of an Adolescent Sexual and Reproductive Health Intervention in Mwanza, Tanzania Completed NCT00248469 Phase 3
13 Gestational Sulfadoxine-pyrimethamine and Azithromycin Treatment to Prevent Preterm Birth Completed NCT00131235 Phase 3 Sulfadoxine-pyrimethamine treatment twice during pregnancy;Sulfadoxine-pyrimethamine at 4-week intervals;Sulfadoxine-pyrimethamine every 4 weeks + azithromycin twice
14 Supplementing Maternal and Infant Diet With High-energy, Micronutrient Fortified Lipid-based Nutrient Supplements (LNS) Completed NCT01239693 Phase 3
15 Improving PRegnancy Outcomes With Intermittent preVEntive Treatment in Africa Not yet recruiting NCT03208179 Phase 3 dihydroartemisinin-piperaquine;sulphadoxine-pyrimethamine;dihydroartemisinin-piperaquine plus azithromycin
16 Evaluate Azithromycin Plus Chloroquine And Sulfadoxine Plus Pyrimethamine Combinations For Intermittent Preventive Treatment Of Falciparum Malaria Infection In Pregnant Women In Africa Terminated NCT01103063 Phase 3 Azithromycin plus chloroquine;sulfadoxine-pyrimethamine
17 Effectiveness of the Diaphragm for HIV Prevention Withdrawn NCT00121459 Phase 3
18 Neo-Penotran Forte Vaginal Suppository for Vaginal Trichomoniasis Completed NCT01361048 Phase 2 oral metronidazole;neo penotran forte;neo penotran forte once a day
19 Topical Metronidazole and Miconazole Co-formulated Vaginal Suppositories for Preventing Vaginal Infections in HIV-seronegative Women Completed NCT01230814 Phase 2 Neo-Penotran® Forte (active ingredient Metronidazole & Miconazole Nitrate);Placebo
20 Study to Improve Partner Services for STD Prevention Completed NCT00207467 Phase 2
21 HIV/STI Risk Reduction for Incarcerated Women With Interpersonal Violence Completed NCT01907126 Phase 2
22 Safety, Acceptability and Preliminary Effectiveness of Carraguard™ (PC-515) in Preventing HIV/STI Transmission Completed NCT00213018 Phase 2 Carraguard (PC-515)
23 Safety, Acceptability and Preliminary Effectiveness of PC-515 for Vaginal Use as a Possible Microbicide Completed NCT00213031 Phase 2 Carraguard (PC-515)
24 The Multimedia HIV/STI Prevention for Drug-Involved Female Offenders Completed NCT01784809 Phase 2
25 HIV/STI Prevention for Drug-Involved Couples Completed NCT01285349 Phase 2
26 Behavioral Intervention to Reduce Sexual and Injection Risks Among Female Sex Workers Who Also Inject Drugs in Mexico Completed NCT00840658 Phase 2
27 NGU: Doxycycline (Plus or Minus Tinidazole) Versus Azithromycin (Plus or Minus Tinidazole) Completed NCT00322465 Phase 2 Tinidazole;Doxycycline;Azithromycin
28 BufferGel and PRO 2000/5: Vaginal Gels to Prevent HIV Infection in Women Completed NCT00074425 Phase 2 BufferGel;PRO 2000/5 Gel;Placebo gel
29 Safer Sex Program for Young African-American Men Recruiting NCT01439503 Phase 2
30 Crossover Bioequivalence Study of Tinidazole 500 mg Tablets Under Fed Conditions Completed NCT01591889 Phase 1 Tinidazole;Tinidazole
31 Safety and Acceptability of Carraguard™ Among HIV-negative Couples in Thailand Completed NCT00213057 Phase 1 Carraguard (PC-515)
32 S.T.A.R.S.: Sistas Talking About Real Solutions Completed NCT01028157 Phase 1
33 "Solana™ Trichomonas Assay Field Study" Unknown status NCT02566447
34 Accuracy and Acceptability of Self-Diagnostic Methods for Vaginitis in Adolescent Females Unknown status NCT00706368
35 The Impact of Short-term Financial Incentives on Sexual Behavior and HIV Incidence in Lesotho Unknown status NCT01589965 Early Phase 1
36 Development and Testing of a Clinic-Based Intervention to Increase Dual Protection Against Unintended Pregnancy and Sexually Transmitted Diseases (STDs) Among High Risk Female Teens Unknown status NCT02291224
37 The Contraceptive Choice Project Unknown status NCT01986439
38 Increased Access to Emergency Contraceptive Pills Unknown status NCT00060463
39 Control of Trichomoniasis Completed NCT00334555
40 Female Urine, Vaginal & Endocervical Swab & Cervical Specimen Collections for APTIMA Trichomonas Vaginalis Assay Testing Completed NCT01427023
41 A Validation Study of Genzyme Diagnostics OSOM Trichomonas Rapid Test and BVBlue Test Completed NCT00682851
42 Comparing NAAT Testing to Standard Methods for the Diagnosis of Vaginitis Completed NCT02203942
43 Cepheid Rectal Sample Validation Study Completed NCT02099760
44 Clinical Study of the Presence of Trichomonas Tenax and Entamoeba Gingivalis in Patients With Periodontitis Completed NCT03178838
45 Validity of Patient-Collected Wet Mounts Completed NCT02641717
46 Non-Invasive Sexually Transmitted Disease Testing in Women Seeking Emergency Contraception or Urine Pregnancy Testing Completed NCT00978848
47 Management of Vaginal Complaints: A Pilot Study Within a Practice-Based Research Network Completed NCT00503542 Early Phase 1 Terazol or oral fluconazole for candidal vaginitis;Metronidazole or Clindamycin for Bacterial Vaginosis;Flagyl for definitively diagnosed vaginal trichomoniasis
48 Observational Program Neo-Penotran® Forte Completed NCT01335373 Metronidazole/Miconazole (Neo-Penotran Forte, BAY86-5276)
49 Four-Arm Randomized Control Trial of Brief MI Versus Couples-Based HIV/STI Prevention in South Africa Completed NCT01554423
50 Rewarding Sexually Transmitted Infection (STI) Prevention and Control in Tanzania Completed NCT00922038

Search NIH Clinical Center for Trichomoniasis

Cochrane evidence based reviews: trichomonas infections

Genetic Tests for Trichomoniasis

Anatomical Context for Trichomoniasis

MalaCards organs/tissues related to Trichomoniasis:

38
Testes, T Cells, Cervix, Colon, Skin

Publications for Trichomoniasis

Articles related to Trichomoniasis:

(show top 50) (show all 542)
# Title Authors Year
1
Humoral and T cell-mediated immune response against trichomoniasis. ( 29266263 )
2018
2
Report of the first clinical case of intestinal trichomoniasis caused by Tritrichomonas foetus in a cat with chronic diarrhoea in Brazil. ( 28412947 )
2017
3
Single-Dose Compared With Multidose Metronidazole for the Treatment of Trichomoniasis in Women: A Meta-Analysis. ( 27898571 )
2017
4
Natural Products as New Treatment Options for Trichomoniasis: A Molecular Docking Investigation. ( 28134827 )
2017
5
Is there an association between trichomoniasis and other sexually transmitted infections in adolescent ED patients? ( 29229536 )
2017
6
A Study on the Prevalence of Genital Trichomoniasis among Female Outpatients Attending Sexually Transmitted Infection Clinic in a Tertiary Care Hospital. ( 28042211 )
2017
7
An evaluation study of the Becton-Dickinson ProbeTec Qx (BDQx) Trichomonas vaginalis trichomoniasis molecular diagnostic test in two large, urban STD services. ( 28108699 )
2017
8
Trichomoniasis and associated co-infections of the genital tract among pregnant women presenting at two hospitals in Ghana. ( 29237446 )
2017
9
Intravaginal boric acid: is it an alternative therapeutic option for vaginal trichomoniasis? ( 29223972 )
2017
10
Recombinant I+-actinin subunit antigens of Trichomonas vaginalis as potential vaccine candidates in protecting against trichomoniasis. ( 28209207 )
2017
11
The prevalence of trichomoniasis and associated factors among women treated at a university hospital in southern Brazil. ( 28346531 )
2017
12
Very low sensitivity of wet mount microscopy compared to PCR against culture in the diagnosis of vaginal trichomoniasis in Uganda: a cross sectional study. ( 28683790 )
2017
13
Diagnosis of Trichomoniasis in Male Patients on Performing Nested Polymerase Chain Reaction. ( 29035239 )
2017
14
Antitrichomonal activity of Peganum harmala alkaloid extract against trichomoniasis in Pigeon (Columba livia domestica). ( 28084792 )
2017
15
A missed diagnosis of trichomoniasis. ( 28085787 )
2017
16
A review of sexually transmitted bovine trichomoniasis and campylobacteriosis affecting cattle reproductive health. ( 26679515 )
2016
17
First report of an outbreak trichomoniasis in turkey in Sistan, Iran. ( 27065599 )
2016
18
Prevalence of Trichomoniasis among 18-48 Year-old Women in Northwest of Iran. ( 28127371 )
2016
19
Comparative analysis of syndromic and PCR-based diagnostic assay reveals misdiagnosis/ overtreatment for trichomoniasis based on subjective judgment in symptomatic patients. ( 27146362 )
2016
20
Can trichomoniasis cause pharyngitis? A case report. ( 28228954 )
2016
21
Challenges and persistent questions in treatment of trichomoniasis. ( 27697044 )
2016
22
Trichomoniasis - are we giving the deserved attention to the most common non-viral sexually transmitted disease worldwide? ( 28357378 )
2016
23
COMPARISON OF PERMANENT STAINING METHODS FOR THE LABORATORY DIAGNOSIS OF TRICHOMONIASIS. ( 26910452 )
2016
24
Trichomoniasis in older individuals: a preliminary report from Iran. ( 27876991 )
2016
25
Diagnosis of trichomoniasis in men by urine cytology. ( 27636204 )
2016
26
Prevalence of Trichomoniasis by PCR in Women Attending Health Screening in Korea. ( 27180577 )
2016
27
A molecular-beacon-based asymmetric PCR assay for easy visualization of amplicons in the diagnosis of trichomoniasis. ( 27318568 )
2016
28
Epidemiology of Trichomoniasis in South Korea and Increasing Trend in Incidence, Health Insurance Review and Assessment 2009-2014. ( 27936227 )
2016
29
Rapid Antigen Testing for Trichomoniasis in an Emergency Department. ( 27207490 )
2016
30
Prevalence of asymptomatic infections in sexually transmitted diseases attendees diagnosed with bacterial vaginosis, vaginal candidiasis, and trichomoniasis. ( 27890946 )
2016
31
Trichomoniasis immunity and the involvement of the purinergic signaling. ( 27793265 )
2016
32
A Diagnostic and Symptomatological Study on Trichomoniasis in Symptomatic Pregnant Women in Rafsanjan, South Central Iran in 2012-13. ( 26622305 )
2015
33
Comparison between mixed lysate antigen and I+-actinin antigen in ELISA for serodiagnosis of trichomoniasis. ( 26072305 )
2015
34
Prevalence of trichomoniasis among women in kermanshah, iran. ( 26019904 )
2015
35
Vulvovaginitis: screening for and management of trichomoniasis, vulvovaginal candidiasis, and bacterial vaginosis. ( 26001874 )
2015
36
Comparative aspects of immunity and vaccination in human and bovine trichomoniasis: a review. ( 26424377 )
2015
37
Comparison of the Effect of Vaginal Zataria multiflora Cream and Oral Metronidazole Pill on Results of Treatments for Vaginal Infections including Trichomoniasis and Bacterial Vaginosis in Women of Reproductive Age. ( 26266260 )
2015
38
A Review of Evidence-Based Care of Symptomatic Trichomoniasis and Asymptomatic Trichomonas vaginalis Infections. ( 26602621 )
2015
39
Epidemiology and treatment of trichomoniasis. ( 25925796 )
2015
40
Trichomoniasis: a brief review of diagnostic methods and our experience with real-time PCR for detecting infection. ( 25770306 )
2015
41
Culture and immunochromatographic technique for diagnosis of trichomoniasis. ( 24682201 )
2014
42
Prevalence of vulvovaginal candidiasis, trichomoniasis and bacterial vaginosis among pregnant women receiving antenatal care in Southwestern Nigeria. ( 25544891 )
2014
43
Neglected parasitic infections in the United States: trichomoniasis. ( 24808247 )
2014
44
Graphene and carbon nanotube composite enabling a new prospective treatment for trichomoniasis disease. ( 24907738 )
2014
45
Epidemiology of undiagnosed trichomoniasis in a probability sample of urban young adults. ( 24626058 )
2014
46
An emerging Mycoplasma associated with trichomoniasis, vaginal infection and disease. ( 25337710 )
2014
47
Counterpoint: Screening for Trichomoniasis--Where's the Evidence of Benefit? ( 24043492 )
2014
48
Prevalence of Trichomoniasis, Vaginal Candidiasis, Genital Herpes, Chlamydiasis, and Actinomycosis among Urban and Rural Women of Haryana, India. ( 26316979 )
2014
49
Risk factors associated with bovine trichomoniasis in beef cattle identified by a questionnaire. ( 24623635 )
2014
50
Trichomoniasis: Is it always sexually transmitted? ( 26396458 )
2014

Variations for Trichomoniasis

Expression for Trichomoniasis

Search GEO for disease gene expression data for Trichomoniasis.

Pathways for Trichomoniasis

Pathways related to Trichomoniasis according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1 11.65 CD79A IL2 IRF6
2
Show member pathways
11.01 CXCL8 IL2 IRF6
3
Show member pathways
10.96 CXCL8 IL2

GO Terms for Trichomoniasis

Sources for Trichomoniasis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
27 GO
28 GTR
29 HGMD
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 MedGen
41 MeSH
42 MESH via Orphanet
43 MGI
45 NCI
46 NCIt
47 NDF-RT
50 NINDS
51 Novoseek
53 OMIM
54 OMIM via Orphanet
58 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....